225ac-psma-617
novartis
['crpc', '225ac', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', ' uc,(-ucsd),(-ucsf),']
a phase i/ii dose-escalation study of fractionated 225ac-j591 for progressive #mcrpc in patients with prior treatment with 177lu-psma. presented by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology